UK Histiocytosis Forum 2021

Histiocytosis UK 2021
Forum on 18th November 2021
The 7th Annual UK Histiocytosis Forum
Hosted by Histio UK
The program includes:

Langerhans Cell Histiocytosis (LCH and Other Rarer)

Abstracts – Q&A
Dr Mark Bishton – Consultant Haematologist, Nottinghamshire University Hospitals Trust:
Hanhua Liu – Senior Cancer Intelligence Analyst, Public Health England; Peter Stilwell – Senior Data Analyst, Public Health England.
Presenting: Histiocytic disease: NDRS approach to understanding rare disease and cancer at a population level. Q&A

Dr. Eli Diamond – Member of the interdisciplinary team at Memorial Sloan Kettering treating and studying patients with histiocytic disorders such as Erdheim-Chester disease and Langerhans cell histiocytosis. Clinical Expertise – Neuro-Oncology; Adult Brain Tumours; Histiocytosis.
QA & Summary

Haemophagocytic lymphohistiocytosis (HLH)

Abstracts Q&A
HLH in Practice
Dr. Rob Sandler– Rheumatology Registrar, Sheffield Teaching Hospitals
Presenting: HLH after Bone Marrow Transplant Q&A
Dr Naina McCann – Infectious Diseases Registrar and Pratyasha Saha Internal Medicine Speciality Trainee, University College London Hospital
Presenting: Cause of death in HLH
Dr. Harry Wilson – Morkeh – Rheumatology Registrar, Hammersmith Hospital
Presenting: HLH in pregnancy Q&A

Dr. Rebecca Marsh – Member of the paediatric haematologist- oncologist team affiliated with Cincinnati Children’s Hospital Medical Center. Presenting: Quercetin Suppresses XIAP Deficiency Associated Hyperinflammation

QA Summary & Closing

1 Points

Previous Article